833-2263234 (USA Toll-free) +1-224-345-1927 (USA) +86-13250544625(Intl) info@editxor.com
在线客服
[Literature Review] CRISPR Screening Innovation: A Novel Tool for Higher-Order Genetic Perturbations

[Literature Review] CRISPR Screening Innovation: A Novel Tool for Higher-Order Genetic Perturbations

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

[Cutting Edge] Gene Editing Breakthrough: PKM1, PBRM1, and S100A9 Knockout Cells Reveal New Cancer Tr

[Cutting Edge] Gene Editing Breakthrough: PKM1, PBRM1, and S100A9 Knockout Cells Reveal New Cancer Tr

The newly upgraded knockout cell bank is now available, featuring 3,800 ready-to-use cell lines, covering a wide range of popular drug targets and highly promising new targets. For the knockout cells you need, trust the gene editing experts at EDITGENE!

[Literature Review] CRISPR Knockout Provides Novel Insight into CENP-E-mediated Cell Division

[Literature Review] CRISPR Knockout Provides Novel Insight into CENP-E-mediated Cell Division

EDITGENE offers a complete one-stop solution for CRISPR library screening, specializing in gene editing for over a decade. We have assembled the most popular CRISPR sgRNA library types in the research community, complemented by our expert team’s attentive service. Everything is …

[Weekly News] CRISPR screening reveals new mechanism: IL-4 contributes to CD8+ CART cell failure

[Weekly News] CRISPR screening reveals new mechanism: IL-4 contributes to CD8+ CART cell failure

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

Prev 1 2 3 4 5 6 7 8 9 10 11 Next